Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons

Neurobiology of Disease

Volumn 22, Issue 2, 2006, Pages 388-400

  Chang, Diane T W ^a   Rintoul, Gordon L ^a   Pandipati, Sruthi ^a   Reynolds, Ian J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Calcium; Cytoskeleton; Glutamate; Huntington; Mitochondria; Neuronal death

Indexed keywords

HUNTINGTIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN CORTEX; CELL STRUCTURE; CONTROLLED STUDY; GENE MUTATION; HUNTINGTON CHOREA; IMMOBILIZED CELL; MITOCHONDRION; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 33646136884     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2005.12.007     Document Type: Article

References (60)

1. Bossy-Wetzel E., Barsoum M.J., Godzik A., Schwarzenbacher R., and Lipton S.A. Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr. Opin. Cell Biol. 15 (2003) 706-716
2. Brocard J.B., Tassetto M., and Reynolds I.J. Quantitative evaluation of mitochondrial calcium content in rat cortical neurones following a glutamate stimulus. J. Physiol. (London) 531 (2001) 793-805
3. Browne S.E., Bowling A.C., MacGarvey U., Baik M.J., Berger S.C., Muqit M.M., Bird E.D., and Beal M.F. Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41 (1997) 646-653
4. Brustovetsky N., Brustovetsky T., Purl K.J., Capano M., Crompton M., and Dubinsky J.M. Increased susceptibility of striatal mitochondria to calcium-induced permeability transition. J. Neurosci. 23 (2003) 4858-4867
5. Chai Y., Koppenhafer S., Shoesmith S., Perez M., and Paulson H. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8 (1999) 673-682
6. Chen S., Berthelier V., Yang W., and Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity1. Mol. Biol. 311 (2001) 173-182
7. Chen S., Berthelier V., Hamilton J.B., O'Nuallain B., and Wetzel R. Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41 (2002) 7391-7399
8. Choo Y.S., Johnson G.V.W., MacDonald M., Detloff P.J., and Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum. Mol. Genet. 13 (2004) 1407-1420
9. Cooper J.K., Schilling G., Peters M.F., Herring W.J., Sharp A.H., Kaminsky Z., Masone J., Khan F.A., Delanoy M., Borchelt D.R., Dawson V.L., Dawson T.M., and Ross C.A. Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7 (1998) 783-790
10. Cornett J., Cao F., Wang C.-E., Ross C.A., Bates G.P., Li S.-H., and Li X.-J. Polyglutamine expansion of huntingtin impairs its nuclear export. Genet 37 (2005) 198-204
11. de la Monte S.M., Vonsattel J.P., and Richardson Jr. E.P. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease. J. Neuropathol. Exp. Neurol. 47 (1988) 516-525
12. De Vos K., Severin F., Van Herreweghe F., Vancompernolle K., Goossens V., Hyman A., and Grooten J. Tumor necrosis factor induces hyperphosphorylation of kinesin light chain and inhibits kinesin-mediated transport of mitochondria. J. Cell Biol. 149 (2000) 1207-1214
13. Gauthier L.R., Charrin B.C., Borrell-Pages M., Dompierre J.P., Rangone H., Cordelieres F.P., De Mey J., MacDonald M.E., Lessmann V., Humbert S., and Saudou F. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118 (2004) 127-138
14. Gossen M., and Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 5547-5551
15. Greene J.G., Sheu S.-S., Gross R.A., and Greenamyre J.T. 3-Nitropropionic acid exacerbates N-methyl-aspartate toxicity in striatal culture by multiple mechanisms. Neuroscience 84 (1998) 503-510
16. Gunawardena S., and Goldstein L.S.B. Polyglutamine diseases and transport problems: deadly traffic jams on neuronal highways. Arch. Neurol. 62 (2005) 46-51
17. Gunawardena S., Her L.-S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., and Goldstein L.S.B. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40 (2003) 25-40
18. Hackam A.S., Singaraja R., Wellington C.L., Metzler M., McCutcheon K., Zhang T., Kalchman M., and Hayden M.R. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141 (1998) 1097-1105
19. Hazeki N., Nakamura K., Goto J., and Kanazawa I. Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract. Biochem. Biophys. Res. Commun. 256 (1999) 361-366
20. Hollenbeck P.J. Products of endocytosis and autophagy are retrieved from axons by regulated retrograde organelle transport. J. Cell Biol. 121 (1993) 305-315
21. Jana N.R., Zemskov E.A., Wang G.-H., and Nukina N. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10 (2001) 1049-1059
22. Jiang H., Nucifora Jr. F.C., Ross C.A., and DeFranco D.B. Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet. 12 (2003) 1-12
23. Kazantsev A., Preisinger E., Dranovsky A., Goldgaber D., and Housman D. Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11404-11409
24. Kuemmerle S., Gutekunst C.A., Klein A.M., Li X.J., Li S.H., Beal M.F., Hersch S.M., and Ferrante R.J. Huntingtin aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46 (1999) 842-849
25. Lee H.C., and Wei Y.H. Mitochondrial role in life and death of the cell. J. Biomed. Sci. 7 (2000) 2-15
26. Lee W.-C.M., Yoshihara M., and Littleton J.T. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3224-3229
27. Li H., Li S.-H., Yu Z.-X., Shelbourne P., and Li X.-J. Huntingtin aggregate-associated axonal degeneration is an early pathological event in Huntington's disease mice. J. Neurosci. 21 (2001) 8473-8481
28. Li H., Wyman T., Yu Z.-X., Li S.-H., and Li X.-J. Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release. Hum. Mol. Genet. 12 (2003) 2021-2030
29. Llopis J., McCaffery J.M., Miyawaki A., Farquhar M.G., and Tsien R.Y. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 6803-6808
30. Ludolph A.C., He F., Spencer P.S., Hammerstad J., and Sabri M. 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18 (1991) 492-498
31. 2+ inhibits mitochondrial movement in neurons by phosphatidylinositol 3-kinase activation. J. Neurosci. 25 (2005) 9507-9514
32. Mann D.M., Oliver R., and Snowden J.S. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathol. (Berl) 85 (1993) 553-559
33. Martin-Aparicio E., Yamamoto A., Hernandez F., Hen R., Avila J., and Lucas J.J. Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease. J. Neurosci. 21 (2001) 8772-8781
34. Meade C.A., Deng Y., Fusco F.R., Del Mar N., Hersch S., Goldowitz D., and Reiner A. Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J. Comp. Neurol. 449 (2002) 241-269
35. Miller K.E., and Sheetz M.P. Axonal mitochondrial transport and potential are correlated. J. Cell Sci. 117 (2004) 2791-2804
36. Mitsui K., Nakayama H., Akagi T., Nekooki M., Ohtawa K., Takio K., Hashikawa T., and Nukina N. Purification of polyglutamine aggregates and identification of elongation factor-1alpha and heat shock protein 84 as aggregate-interacting proteins. J. Neurosci. 22 (2002) 9267-9277
37. Nucifora Jr. F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., and Ross C.A. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291 (2001) 2423-2428
38. Panov A.V., Gutekunst C.A., Leavitt B.R., Hayden M.R., Burke J.R., Strittmatter W.J., and Greenamyre J.T. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5 (2002) 731-736
39. 2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. Arch. Biochem. Biophys. 410 (2003) 1-6
40. 2+-induced permeability transition in human lymphoblastoid cell mitochondria from normal and Huntington's disease individuals. Mol. Cell. Biochem. 269 (2005) 143-152
41. Perez M.K., Paulson H.L., Pendse S.J., Saionz S.J., Bonini N.M., and Pittman R.N. Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol. 143 (1998) 1457-1470
42. Rintoul G.L., Filiano A.J., Brocard J.B., Kress G.J., and Reynolds I.J. Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J. Neurosci. 23 (2003) 7881-7888
43. Ruan Q., Lesort M., MacDonald M.E., and Johnson G.V.W. Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway. Hum. Mol. Genet. 13 (2004) 669-681
44. Rubinsztein D.C. Lessons from animal models of Huntington's disease. Trends Genet. 18 (2002) 202-209
45. Saulle E., Gubellini P., Picconi B., Centonze D., Tropepi D., Pisani A., Morari M., Marti M., Rossi L., and Papa M. Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease. Mol. Cell. Neurosci. 25 (2004) 9-20
46. Scherzinger E., Sittler A., Schweiger K., Heiser V., Lurz R., Hasenbank R., Bates G.P., Lehrach H., and Wanker E.E. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4604-4609
47. Schon E.A., and Manfredi G. Neuronal degeneration and mitochondrial dysfunction. J. Clin. Invest. 111 (2003) 303-312
48. Sipione S., and Cattaneo E. Modeling Huntington's disease in cells, flies and mice. Mol. Neurobiol. 23 (2001) 21-51
49. Snider B.J., Moss J.L., Revilla F.J., Lee C.-S., Wheeler V.C., Macdonald M.E., and Choi D.W. Neocortical neurons cultured from mice with expanded cag repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults. Neuroscience 120 (2003) 617-625
50. Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.-Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., and Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 6763-6768
51. Szebenyi G., Morfini G.A., Babcock A., Gould M., Selkoe K., Stenoien D.L., Young M., Faber P.W., MacDonald M.E., McPhaul M.J., and Brady S.T. Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40 (2003) 41-52
52. Tolkovsky A.M., Xue L., Fletcher G.C., and Borutaite V. Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease?. Biochimie 84 (2002) 233-240
53. Trushina E., Heldebrant M.P., Perez-Terzic C.M., Bortolon R., Kovtun I.V., Badger II J.D., Terzic A., Estevez A., Windebank A.J., Dyer R.B., Yao J., and McMurray C.T. Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 12171-12176
54. Trushina E., Dyer R.B., Badger II J.D., Ure D., Eide L., Tran D.D., Vrieze B.T., Legendre-Guillemin V., McPherson P.S., Mandavilli B.S., Van Houten B., Zeitlin S., McNiven M., Aebersold R., Hayden M., Parisi J.E., Seeberg E., Dragatsis I., Doyle K., Bender A., Chacko C., and McMurray C.T. Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol. Cell. Biol. 24 (2004) 8195-8209
55. Vanden Berghe P., Hennig G.W., and Smith T.K. Characteristics of intermittent mitochondrial transport in guinea pig enteric nerve fibers. Am. J. Physiol.: Gastrointest. Liver Physiol. 286 (2004) G671-G682
56. Wellington C.L., Singaraja R., Ellerby L., Savill J., Roy S., Leavitt B., Cattaneo E., Hackam A., Sharp A., Thornberry N., Nicholson D.W., Bredesen D.E., and Hayden M.R. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275 (2000) 19831-19838
57. Xia Z., Dudek H., Miranti C.K., and Greenberg M.E. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 16 (1996) 5425-5436
58. Xia J., Lee D.H., Taylor J., Vandelft M., and Truant R. Huntingtin contains a highly conserved nuclear export signal. Hum. Mol. Genet. 12 (2003) 1393-1403
59. Yu Z.-X., Li S.-H., Evans J., Pillarisetti A., Li H., and Li X.-J. Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J. Neurosci. 23 (2003) 2193-2202
60. Zeron M.M., Chen N., Moshaver A., Ting-Chun Lee A., Wellington C.L., Hayden M.R., and Raymond L.A. Mutant huntingtin enhances excitotoxic cell death. Mol. Cell. Neurosci. 17 (2001) 41-53